Clinical RoundupFree Lynparza in the adjuvant treatment of patients with germline BRCA1/2 mutations and high-risk early breast cancer reduced the risk of cancer recurrence by 42% in OlympiA phase III trial June 04, 2021Vol.47 No.22
Clinical RoundupFree Choice of first-line platinum regimen does not significantly impact efficacy of second-line immunotherapy in advanced bladder cancer June 04, 2021Vol.47 No.22
Clinical RoundupFree Survey: Cancer patients and survivors continue to face pandemic-related health care delays one year later June 04, 2021Vol.47 No.22
Clinical RoundupFree Dual immunotherapy regimen delays cancer progression in patients with advanced melanoma June 04, 2021Vol.47 No.22
Clinical RoundupFree Researchers discover gene linked to bone cancer in children, identify potential novel therapy June 04, 2021Vol.47 No.22
Drugs & TargetsFree Truseltiq receives FDA accelerated approval for metastatic cholangiocarcinoma June 04, 2021Vol.47 No.22
Drugs & TargetsFree Lumakras receives FDA accelerated approval for KRAS G12C mutated NSCLC June 04, 2021Vol.47 No.22
Drugs & TargetsFree European Commission approves Opdivo + Yervoy as first-line treatment for unresectable malignant pleural mesothelioma June 04, 2021Vol.47 No.22
Free Prominent GI oncologist Axel Grothey was forced out of Mayo Clinic for unethical sexual relationships with women he mentoredThree reprimands later, he retains leadership—and mentorship—positions May 28, 2021Vol.47 No.21By Alexandria Carolan and Paul Goldberg
